跳至主要内容
临床试验/CTRI/2014/07/004740
CTRI/2014/07/004740已完成未知

Efficacy of Ranitidine in Olanzapine induced weight gain: A dose response study

Central Institute of Psychiatry0 个研究点目标入组 75 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Subjects satisfying the ICD 10 criteria for schizophrenia admitted in institute as their first episode.
  • 2. Drug free patients for minimum 4weeks on oral antipsychotics and 8 weeks on depot preparation.
  • 3. Those giving written informed consent for study

排除标准

  • 1. Any other major comorbid psychiatric diagnosis and substance dependence excluding nicotine and caffeine.
  • 2. Presence of significant medical or neurological illness.
  • 3. BMI > 30kg/m2
  • 4. Not ready for consent

研究者

相似试验